Adipositas Care & Health Therapy

NCT ID: NCT04768127

Last Updated: 2025-04-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

NA

Total Enrollment

586 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-05-15

Study Completion Date

2025-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

ACHT - Adipositas Care and Health Therapy - is a structured, digitally-supported, cross-sectoral and close to home program developed for the postoperative care of patients following obesity surgery. The aim is to ensure the long-term success of therapy following bariatric surgery. ACHT was selected by the Federal Joint Commission for support under the Innovation Fund. The project started in July 2019 and will end in December 2022.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In Germany, every second adult is overweight and almost one in four is obese - the trend is rising. Obesity is a chronic illness which significantly increases the risk of developing co-morbidities such as cardiovascular and joint diseases, cancer and diabetes. In addition to those functional and health limitations, many people are stigmatised which can lead to social exclusion and a reduced quality of life. Available conservative therapies do not always lead to sufficient, long-term weight loss. In those cases and if the disease is very pronounced, an obesity surgery (bariatric-metabolic surgery) can help. In order to ensure its success, patients require long-term after care following surgery. Currently, there are no necessary outpatient care standards and provisions. Inpatient obesity centres try to compensate for this with their own structures and limited resources, but are already reaching their limits.

The aim of the ACHT project is to ensure long-term therapeutic success after an operation. This is done through a digitally supported, structured, cross-sectoral and close-to-home aftercare program. Obesity case managers (obesity guides) coordinate the aftercare process and monitor the therapy goals. A digital case file links patients, case managers, resident doctors and obesity centers. Individual exercise goals, nutritional advice and psychological support are part of ACHT. ACHT is connected to quality assurance measures of a medical society.

Four groups are compared in the ACHT study. One group begins their 18 months ACHT aftercare program directly after the operation, another group 18 months after the operation. These two groups are compared to patients who receive standard care. Through these two intervention groups, we hope to examine the long-term effects of the program within the given time constraints of the study.

ACHT is funded for three and a half years by the Federal Joint Committee as part of the Innovation Fund with approx. 4.5 million euros.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Patients After Metabolic-bariatric Surgery Obesity, Morbid

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

The study will compare two intervention groups (early intervention and later intervention) to two control groups.
Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Early aftercare (intervention group 1)

Patients in this group will begin the ACHT program immediately after their bariatric metabolic operation. 3 weeks post surgery, they will attend the initial examination and meet their case manager. The obesity guide will then set up an electronic case file for the patient and introduce the patient to the obesity app. Through the next 18 months the obesity guide will monitor the patient's therapeutic success and adherence to the therapeutic goals. In month 2 patients visit a sports physician who assesses their mobility and physical capacity to compile a personal training plan, which will be uploaded onto the patient's case file and thus be available to the patient via the app. In months 3,6,9.12 and 18, patients will attend their aftercare appointments at specially trained ACHT physicians, where they will be physically examined by a physician and receive tailored dietary advice from a nutritional advisor. In month 18 patients revisit the surgical centre for the follow-up examination

Group Type EXPERIMENTAL

early aftercare

Intervention Type OTHER

This group begins the aftercare program immediately after their bariatric surgery.

Mid-term to long-term aftercare (intervention group 2)

Patients in this group first visit the study center 18 months after their bariatric surgery for the initial examination and start the program in month 19 post-op. At the center, they will meet their obesity guide who will set up an electronic case file for the patient and introduce the patient to the obesity app. Throughout the next 18 months, the obesity guide will monitor the patient's therapeutic success and adherence to the therapeutic goals. In month 19 post-surgery, patients visit a sports physician who assesses their mobility and devises a personal training plan. This plan will be uploaded onto the patient's case file and made available to the patient via the app. In months 19,21,24, 30 and 36, patients attend their aftercare appointments at specially trained ACHT physicians, where they will be physically examined and receive tailored dietary advice. In month 36, patients will be reexamined at the study center.

Group Type EXPERIMENTAL

mid-term to late aftercare

Intervention Type OTHER

This group begins the aftercare program 18 months post surgery.

control group 1 (early aftercare)

Analogous to intervention group I, patients in this group are invited to the study center after verbal and written information. These patients will attend the one-off evaluation examination (18 months after the operation) at the obesity centre.

If interested, patients in this group can be included in intervention group II until the required number of cases (140 patients) has been reached.

Group Type NO_INTERVENTION

No interventions assigned to this group

control group 2 (mid-term to long-term aftercare)

Analogous to intervention group II, patients in this group are invited to the study center after verbal and written information. These patients will attend the one-off evaluation examination at the study center 36 months after the operation.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

early aftercare

This group begins the aftercare program immediately after their bariatric surgery.

Intervention Type OTHER

mid-term to late aftercare

This group begins the aftercare program 18 months post surgery.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

relevant for all groups:

* patients who have already approved to have their data entered into the National Registry of metabolic and bariatric diseases (StuDoQ, DGAV)
* Sufficient knowledge of the German language to use the app, to communicate with the obesity case manager (obesity guide) and to fill out the questionnaires
* signed consent form

group specific criteria:

Intervention group I ("early aftercare"):

* Insured with the Allgemeine Ortskrankenkasse (AOK) Bayern
* Consent to participate in the selective contract
* The bariatric metabolic operation (sleeve gastrectomy, Roux-en-Y-gastric bypass) was carried out 3 weeks (+/- 10 days) before the entrance examination
* iOS or Android smartphone (operating system: iOS 11 or higher or Android 6 or higher) with internet access can be used for study
* Sufficient mobility to get to the aftercare practice regularly and to complete an exercise program

Intervention Group II ("medium-term and late after care") recruited from control group I:

* Insured with the Allgemeine Ortskrankenkasse (AOK) Bayern
* Consent to participate in the selective contract
* The bariatric-metabolic operation (sleeve gastrectomy or Roux-en-Y-gastric bypass) was carried out 18 months (+/- 2 months) before time of recruitment

Control group I (compared to early intervention):

* Insured with the Allgemeine Ortskrankenkasse (AOK) Bayern
* The bariatric metabolic operation was carried out 18 months (+/- 2 months) before time of recruitment
* Sufficient mobility (see intervention group, so that groups are comparable)

Control group II (compared to late intervention):

* The bariatric metabolic operation was carried out 36 months (+/- 2 months) before the recruitment date
* Sufficient mobility (see intervention group, so that groups are comparable)
* The health insurance is irrelevant in this group

Exclusion Criteria

* State after a revision operation
* Planned two-stage surgical procedure
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Deutsche Stiftung für chronisch Kranke

UNKNOWN

Sponsor Role collaborator

Deutschen Gesellschaft für Allgemein- und Viszeralchirurgie e.V. (DGAV)

UNKNOWN

Sponsor Role collaborator

AOK Bayern

INDUSTRY

Sponsor Role collaborator

Kassenärztliche Vereinigung Bayern

UNKNOWN

Sponsor Role collaborator

symeda GmbH

UNKNOWN

Sponsor Role collaborator

AMC Wolfartklinik Gräfelfing

UNKNOWN

Sponsor Role collaborator

Schön Klinik Nürnberg Fürth

UNKNOWN

Sponsor Role collaborator

Dr. Lubos Kliniken Bogenhausen

UNKNOWN

Sponsor Role collaborator

Klinikum Memmingen

UNKNOWN

Sponsor Role collaborator

Klinikum Passau

UNKNOWN

Sponsor Role collaborator

Klinikum Nürnberg

OTHER

Sponsor Role collaborator

Helmholtz Zentrum München

INDUSTRY

Sponsor Role collaborator

Wuerzburg University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Martin Fassnacht

Prof. Dr. Martin Fassnacht (Head of Endocrinolgy)

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Bettina Zippel-Schultz, PhD

Role: STUDY_DIRECTOR

Deutsche Stiftung für chronisch Kranke

Martin Fassnacht, MD

Role: PRINCIPAL_INVESTIGATOR

Wuerzburg University Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

AMC WolfartKlinik, Zentrum für Adipositas- und Metabolische Chirurgie

Gräfelfing, , Germany

Site Status

Adipositaszentrum Klinikum Memmingen

Memmingen, , Germany

Site Status

Chirurgische Klinik München-Bogenhausen GmbH

München, , Germany

Site Status

Klinikum Nürberg

Nuremberg, , Germany

Site Status

Sana Klinikum Offenbach GmbH

Offenbach, , Germany

Site Status

Klinikum Passau

Passau, , Germany

Site Status

Wuerzburg University Hospital

Würzburg, , Germany

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Germany

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ACHT

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Endoscopic Metabolic and Bariatric Therapies
NCT05725967 ENROLLING_BY_INVITATION
Study of Bariatric Surgery
NCT02857179 RECRUITING
The Bariatric Surgery Registry
NCT03441451 RECRUITING